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Abstract- Cerebrovascular attack (CVA) and transient ischemic attack (TIA) are major causes of emergency 
department visits around the globe. A significant number of these patients may experience repeat attacks if 
left untreated. Several risk stratifying scoring systems have been developed in recent years to point out the 
high risk patients. ABCD2 is based on age, blood pressure, clinical status, diabetes mellitus, and duration of 
symptoms and is used commonly for this purpose. In this study, we were to enhance its sensitivity and 
specificity with the addition of another criterion namely atrial fibrillation and making ABCD2-F. A 
prospective study in two hospitals was performed and 138 patients diagnosed with TIA/CVA were enrolled. 
Demographic, clinical, and paraclinical data of all patients were registered. All patients were followed for 
three months for any sign or symptom of a recurrent ischemic attack. Recurrent ischemic attacks happened in 
9.4% of the patients. None of the criteria of ABCD2-F was associated with higher chance of ischemic attacks. 
Similarly, ABCD2-F was not different between patients with or without repeat cerebral ischemia. The addition 
of atrial fibrillation to ABCD2 did not enhance the accuracy of this scoring system to detect patients high risk 
for repeat cerebral ischemia. More studies in the future to improve sensitivity and specificity of this test are 
warranted. 
© 2016 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
In spite of advances in diagnostic and therapeutic 
approaches, cerebral vascular accident (CVA) is still a 
leading cause of morbidity and mortality worldwide 
(1,2). Patients diagnosed with transient ischemic attack 
(TIA) are prone to developing CVA in the near future, 
and several attempts have been made to diagnose this 
high risk group and start preventive measures as early as 
possible (3). Differentiating those at risk to develop 
CVA from the others helps the physician to limit the 
duration of hospitalization and unnecessary treatments 
in low risk patients.  
For this purpose, several risk stratifying methods 
have been proposed in the last decade. ABCD
–a
 
mnemonic standing for age, blood pressure, clinical 
status, and duration of symptoms – was used to stratify 
these patients according to simple clinical and para-
clinical findings (4). Several modifications of this 
scoring system such as ABCD
2
, ABCD
3
, and ABCD
3-I 
were made to improve its accuracy in detecting high risk 
patients (5,6). 
In our previous report, we examined the accuracy of 
ABCD
2
 in predicting the occurrence of TIA/CVA where 
sensitivity and specificity of ABCD
2
 score for predicting 
CVA/TIA at the cut-off point of 4 turned out to be 
72.7% and 52.8%, respectively (7). So, it seems that low 
risk patients according to ABCD
2
, still harbor the 
considerable risk of developing CVA/TIAs. As atrial 
fibrillation (AF) is a well-known risk factor for 
CVA/TIA, in the next step of our studies we decided to 
add this criterion to ABCD
2
 – making ABCD2-F scoring - 
to enhance its accuracy in predicting ischemic events in 
the future.  
 
Materials and Methods 
 
Patients diagnosed with CVA/TIA referred to the 
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Emergency Department (ED) of Rasoul Akram or Sina 
Hospitals in Tehran were enrolled. The study was 
approved by the Ethics Committee of Tehran University 
of Medical Sciences. All demographic information, past 
medical and drug histories, physical examinations of the 
patients were registered by the physicians. All the 
patients underwent paraclinical studies including ECG, 
echocardiography, color-Doppler of cervical vessels, 
MRI and CT-scan findings, and laboratory data. Patients 
with hemorrhagic stroke were excluded. The final goal 
of the study was defined as any neurological deficits 
within 90 days from the first symptoms. Follow-up visits 
of the patients were registered. All the patients were 
contacted by telephone 90 days after the first event and 
asked for symptoms of TIA/CVA. All the forms were 
filled by residents of emergency medicine. TIA was 
defined as neurological event resolving in less than 24 
hours while longer deficits were considered CVA. 
Patients presenting with an only headache or dizziness 
were not included. The final diagnosis was made by a 
neurologist in all cases based on clinical data. As 
reperfusion therapies for stroke have not become a 
common practice in our center, none of the patients 
underwent such treatment. 
Indices of ABCD
2–F
 were scored as follow: 1 point 
for age>60, 1 point for systolic blood pressure>140 mm-
Hg and/or diastolic blood pressure>90 mm-Hg, 1 point 
for any clinical symptoms, 1 point for isolated speech 
disturbance or 2 points for unilateral weakness, 1 point 
for history of diabetes, 1 point for duration of symptoms 
between 10–59 minutes or 2 points for longer duration, 
1 point for atrial fibrillation on ECG. Time to discharge 
the patient and prescribed medications were left to the 
physician’s discretion.  
Collected data were analyzed with SPSS (Version 
18.0, IBM). Kolmogorov-Smirnov test was used to 
evaluate the normal distribution of the data and 
Independent-samples T test, Mann-Whitney U (MWU), 
or Chi-square (χ2) tests were used where indicated. Data 
throughout the manuscript are presented as 
mean±standard error of the mean. Statistical significance 
was defined as P.values less than 0.05. 
 
Results 
 
This study included 138 patients of which 106 
(76.8%) were diagnosed with CVA and the others with 
TIA (23.2%). The mean age of the patients was 
65.48±12.03 years, and 89 patients were male (64.5%). 
Forty four patients (31.8%) were younger than 60, and 
the others were older. Of all the patients, 44 patients 
(31.8%) showed any type of cardiac dysrhythmia, 
arterial fibrillation (AF), block, or ischemic changes in 
their ECG where 9 of them (6.5%) had AF. Thirty two 
patients (23.2%) used to smoke. Past medical history of 
hypertension was positive in 78 (56.5%), CVA or TIA in 
20 (14.5%), ischemic heart diseases in 34 (24.6%), 
diabetes in 39 (28.2%), dyslipidemia in 21 (15.2%) of 
patients. Drug history was positive in 34 (24.6%) 
patients for antiplatelets (aspirin, clopidogrel, or both), 
in 5 (3.6%) for warfarin, and in three (2.1%) for a 
combination of them. Systolic blood pressure at 
presentation was 146.8±25.8 mmHg. Forty eight patients 
(34.7%) had an initial blood pressure of less than 140/90 
mmHg, and the others (65.4%) had higher blood 
pressure.  
Isolated speech disturbances were observed in 17 
(12.3%), isolated posterior circulation symptoms in 22 
(15.9%), and hemiparesis in 99 (71.7%), of the patients. 
Of 32 patients with TIA, duration of signs and 
symptoms was less than 10 minutes in 6 (4.3%) patients, 
between 10-59 minutes in 9 (6.5%), and longer time 
period in the other patients. 
Echocardiography was performed in 122 patients 
whose findings were normal in 86 (70.5%) patients 
whereas some abnormalities including thrombosis in the 
left ventricle, abnormal wall movement, aneurysmal 
wall, or considerable valvular abnormalities were seen 
in the others. Ejection fraction was 50.5±9.5 % on 
average. 
All patients underwent brain CT-scan while MRI 
was performed in only 72 subjects. Brain CT-scan and 
MRI showed some degree of abnormalities in 76(55.1%) 
and 52 (72.2%) of cases, respectively. The mean of 
NIHSS (National Institutes of Health Stroke Scale) was 
1.0±0.3 in TIA patients and 8.3±0.5 in CVA. TIA 
patients were hospitalized for 5.3±0.5 days while CVA 
patients for 8.9±0.8 days. 
Follow-up phone calls, outpatient, and ED visits 
revealed that 13 (9.4%) patients experienced at least one 
attack of CVA/TIA within 90 days from the first 
symptoms. There was no significant difference in age of 
the patients with and without repeat CVA/TIA (T-test, 
P>0.05). Also, of those younger than 60, 3 patients 
(6.8%) and of those older than 60, 10 patients (10.6%) 
experienced new CVA/TIAs where this difference was 
not statistically significant (χ2, P>0.05). Of patients with 
normal electrocardiography (ECG), AF rhythm, and 
other abnormalities in ECG, 6 (6.4%), 2 (22.2%), and 5 
(14.3%) cases developed new CVA/TIAs in their 
follow-up, respectively. However, these differences 
were not significant (χ2, P>0.05).  
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Among the patients with initial blood pressure of less 
than 140/90 mm-Hg, 4 (8.3%) had new stroke symptoms 
while this happened in 8 (9.1%) of patients with higher 
blood pressure at presentation. Again, the difference was 
not significant (χ2, P>0.05).  
Three (7.7%) of the diabetic patients 3 (7.7%) and 10 
(10.1%) of non-diabetic subjects developed new 
TIA/CVA (χ2, P>0.05).  
There was no significant difference in the 
development of new TIA/CVAs in patients with 
hemiparesis (7.0%) compared with patients with other 
symptoms (15.3%) (χ2, P>0.05).  
In TIA patients with their duration of symptoms less 
than 10 minutes, between 10-60 minutes, and longer 
than 60 minutes, 1 (16.7%), 2 (22.2%), and 10 (8.1%) 
developed new CVA/TIAs, respectively. These 
differences were not statistically significant (χ2, 
P>0.05). 
ABCD
2
 and ABCD
2
F did not show any significant 
differences between those with or without repeat 
TIA/CVA (MWU, P>0.05).  
 
Discussion 
 
Although several attempts have been made in the last 
decade to stratify the risk of developing TIA/CVA after 
an initial attack with the help of ABCD or its variants, 
based on our recent studies, this scoring system seems 
unlikely to roughly differentiate high risk patients. 
Maybe adding or changing some criterion in this 
classification system improves its accuracy in the future 
studies. 
In our study, the chance of repeat TIA/CVA within 
the first 3 months after the primary attack was 9.4% (13 
patients) which is similar to other studies (8,9). So, non-
significant results of our study cannot be attributed to a 
lower or higher incidence of stroke in our series. 
In contrast with first reports of ABCD scoring, later 
studies did not show consistent results and cast some 
doubts over its reliability to predict early ischemic 
events after TIA/CVA. A multi-centre prospective study 
with 1667 patients included showed that ABCD
2
 is a 
poor predictor of recurrent ischemic attacks (10). Also, 
another multi-centre study from Canada, which included 
2056 patients, demonstrated ABCD
2
 as an inaccurate 
predictor of early ischemic stroke (11). 
Considering the above mentioned studies which 
undermined the accuracy of ABCD
2
 to predict ischemic 
strokes, several modifications with the addition of 
laboratory or imaging studies were evaluate to improve 
its prognostic accuracy. In a recent study by Kiyohara et 
al., the authors found that ABCD
3
 and ABCD
3-I 
were 
better prognostic scoring systems than ABCD
2
 (6). In 
ABCD
3, third “D” is related to dual TIA (i.e. two 
episodes of TIA within 1 week) is added to ABCD
2
. In 
ABCD
3-I, “I” stands for imaging and requires MRI or 
MR Angiography, which is not available in all centers 
and looks impractical. On the other hand, the addition of 
biomarkers to ABCD systems has also been investigated 
by some authors. In another multicentric prospective 
study, Copeptin enhanced the prognostic value of 
ABCD
2
 and ABCD
3-I
 and (8). Although it was not 
associated with recurrent TIA or ischemic events on the 
whole, it was significantly associated with stroke. 
Ottaviani et al., showed that carotid ultrasound and brain 
CT-scan can improve the value of ABCD
2
 to predict 30 
day ischemic stroke after TIA (9). 
In our patients, none of the six criteria used in 
ABCD
2-F
 was significantly different between those with 
or without TIA/CVA in 3 month follow-up. Also, 
neither ABCD
2
 nor ABCD
2-F
 was significantly higher in 
the group of patients who experienced repeat TIA/CVA. 
Association of AF and stroke has been widely discussed 
in the literature (12). Therefore, it is rational to consider 
it a useful predictive factor. However, our results 
showed that AF neither on its own nor in combination 
with ABCD
2
 is capable of predicting repeat TIA/CVA. 
After analyzing our findings in the last two studies 
and reviewing the literature, we should conclude that 
ABCD scoring and its variants are not capable of 
predicting low risk group of patients to be discharged 
earlier or excluded from medical treatment. However, 
new modifications with the addition of ultrasound, 
imaging, or laboratory studies might be promising in the 
future. 
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